Where do we go now with low molecular weight heparin use in obstetric care?
Authors:
- 1 September 2008
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 6 (9) , 1461-1467
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Antenatal pulmonary embolism: risk factors, management and outcomesBJOG: An International Journal of Obstetrics & Gynaecology, 2008
- The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey*British Journal of Haematology, 2007
- Fondaparinux is a safe alternative in case of heparin intolerance during pregnancyBlood, 2006
- Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valvesThe Journal of Maternal-Fetal & Neonatal Medicine, 2006
- Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? NoJournal of Thrombosis and Haemostasis, 2005
- Low molecular weight heparin in pregnancy: current issuesBritish Journal of Haematology, 2005
- Pregnancy-Induced Changes in PharmacokineticsClinical Pharmacokinetics, 2005
- Minor Transplacental Passage of Fondaparinux in VivoNew England Journal of Medicine, 2004
- Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period2002
- SERIAL CHANGES IN 24 HOUR CREATININE CLEARANCE DURING NORMAL MENSTRUAL CYCLES AND THE FIRST TRIMESTER OF PREGNANCYBJOG: An International Journal of Obstetrics & Gynaecology, 1981